Corona Remedies IPO

Corona Remedies Limited (CORONA) · mainboard IPO on NSE and BSE · 100% Book Building. Listed on 15 December 2025.

Listed 15 Dec Subscribed 137x Listing gain +38.4%

Issue details

Price band
₹1,008–1,062
Issue price
₹1,062
Lot size
14 shares
Min. retail bid
₹14,868
Max. retail bid
13 lots (₹1,93,284)
Issue size
₹691 Cr
Face value
₹10
Bidding
08 Dec – 10 Dec 2025
Listing
15 Dec 2025
Retail quota
35%
Registrar
Bigshare Services Private Limited
ISIN
INE02ZQ01018
Discount
Rs. 54 per equity share is being offered to Eligible Employees

Listing day

Listed at
₹1,470
+38.4% vs issue price ₹1,062
Day's high
₹1,498
+41.0% · low ₹1,413 (+33.0%)
Day's close
₹1,438
+35.4% · traded ₹1,879 Cr
Latest close
₹2,044
+92.5% vs issue · 22 Oct 2026

Back-tested estimate (from a model that had only seen earlier years' IPOs): listing gain +69.8% (likely range +40% to +96%), day's high +69.8%, chance of a gain 92%. Actual: +38.4% at the open, +41.0% at the high.

Subscription status

CategoryShares offeredShares bid forSubscribed
QIB (institutions) 12,88,73235,89,39,448 279x
NII (HNI) total 9,66,54920,18,97,066 209x
Big NII (above ₹10 lakh) 6,44,36615,07,93,356 234x
Small NII (₹2-10 lakh) 3,22,1835,11,03,710 159x
Retail 22,55,2816,48,02,038 28.7x
Employees 61,3209,02,888 14.7x
Total 45,71,88262,65,41,440 137x

Bids on NSE and BSE together, as published by NSE, as of 10 Dec 2025, 07:00 PM. Shares offered exclude the anchor portion. 9% of all shares bid for were at the cut-off price.

Past IPOs with similar demand

Earlier mainboard IPOs whose QIB, NII and retail subscription and size were closest to Corona Remedies's, and how they listed.

IPOQIBNIIRetailTotalSizeListing gainDay high
Data Patterns (India)Dec 2021 191x254x 23.1x120x ₹587 Cr +46.3%+47.7%
GNG ElectronicsJul 2025 266x228x 46.8x148x ₹479 Cr +49.8%+51.6%
Laxmi Organic IndustriesMar 2021 175x218x 20.1x107x ₹605 Cr +19.6%+34.3%
DEE Development EngineersJun 2024 202x144x 23.4x99.6x ₹431 Cr +67.0%+80.2%
Unimech Aerospace and ManufacturingDec 2024 318x264x 56.7x175x ₹527 Cr +86.0%+89.2%
Indigo PaintsJan 2021 190x263x 15.9x117x ₹1,170 Cr +75.0%+110.0%

Lead managers and their listing record

Book running lead managerMainboard IPOs since 2019Avg listing gainListed at a premium
JM Financial 109+22.8%75%
IIFL Capital Services 94+19.3%71%
Kotak Mahindra Capital Company 83+20.8%76%

Offer documents (NSE)

Frequently asked

What is the Corona Remedies IPO price band and lot size? ₹1,008–1,062 per share, with a lot of 14 shares, so the smallest retail bid is ₹14,868.

How many times has it been subscribed? 137x overall: QIB 279x, NII 209x, retail 28.7x, employees 14.7x.

How did it list? It opened at ₹1,470, +38.4% against the issue price of ₹1,062, and closed its first day +35.4%.

Other IPOs of 2025

Important: The AI listing estimates on Flash Finance are statistical estimates drawn from how past Indian IPOs have listed. They are not a forecast of what any IPO will do, not a recommendation to apply, buy or sell, and not investment advice. Listing prices depend on market conditions on the listing day and can differ widely from any estimate; past patterns may not repeat. Subscription figures are as published by NSE (bids on NSE and BSE together) and can be revised. Flash Finance is not a SEBI-registered investment adviser or research analyst. Read the issue's Red Herring Prospectus and consult a SEBI-registered adviser before you invest.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI